Meihua International Medical Technologies (MHUA) Stock Price, News & Analysis

Company Overview

Meihua International Medical Technologies Inc. is a Nasdaq‐listed company primarily engaged in the development, manufacturing and distribution of disposable medical gloves. Through its wholly owned operating subsidiaries in Wenzhou, Zhejiang Province, China, Meihua produces a range of nitrile and latex gloves designed for medical, industrial and consumer applications. The company’s operations include end‐to‐end glove production—from raw material processing to finished goods packaging—ensuring quality control across each stage of manufacture.

The company’s product offering comprises examination gloves, surgical gloves, industrial‐use gloves and household gloves. Meihua’s manufacturing facilities are equipped with automated dipping lines and cleanroom environments to meet stringent regulatory standards. Its products carry U.S. Food and Drug Administration (FDA) registration as well as CE marking, supporting distribution to healthcare providers and industrial end‐users across China, North America and Europe.

Meihua International Medical Technologies was founded in 2019 and completed its initial public offering on the Nasdaq in April 2020. Under the leadership of Chairman and Chief Executive Officer Steven Fang, the company has rapidly scaled production capacity to address global demand for personal protective equipment. Going forward, Meihua plans to invest in expanded manufacturing infrastructure and broaden its sales channels to strengthen its position in the international medical supply market.

Key Stats

• Today's Range: $0.37 to $0.39
• 50-Day Range: $0.37 to $0.48
• 52-Week Range: $0.25 to $1.17
• Volume: 71,727 shs
• Average Volume: 203,110 shs
• Market Capitalization: $11.80 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Meihua International Medical Technologies Stock Analysis - MarketRank™

Meihua International Medical Technologies scored higher than 36% of companies evaluated by MarketBeat, and ranked 779th out of 952 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Meihua International Medical Technologies.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

Meihua International Medical Technologies has a P/B Ratio of 0.06. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.12% of the float of Meihua International Medical Technologies has been sold short.

Short Interest Ratio / Days to Cover

Meihua International Medical Technologies has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Meihua International Medical Technologies has recently decreased by 29.49%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Meihua International Medical Technologies does not currently pay a dividend.

Dividend Growth

Meihua International Medical Technologies does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.12% of the float of Meihua International Medical Technologies has been sold short.

Short Interest Ratio / Days to Cover

Meihua International Medical Technologies has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Meihua International Medical Technologies has recently decreased by 29.49%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 3.8 / 5
• News Sentiment: N/A

News Sentiment

Meihua International Medical Technologies has a news sentiment score of 1.91. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.02 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Meihua International Medical Technologies this week, compared to 0 articles on an average week.

Search Interest

5 people have searched for MHUA on MarketBeat in the last 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Meihua International Medical Technologies insiders have not sold or bought any company stock.

Percentage Held by Insiders

66.56% of the stock of Meihua International Medical Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 1.17% of the stock of Meihua International Medical Technologies is held by institutions.

MHUA Stock Analysis - Frequently Asked Questions

How have MHUA shares performed this year?

Meihua International Medical Technologies' stock was trading at $0.3451 at the start of the year. Since then, MHUA stock has increased by 7.2% and is now trading at $0.37.

When did Meihua International Medical Technologies IPO?

Meihua International Medical Technologies (MHUA) raised $50 million in an initial public offering on Wednesday, February 16th 2022. The company issued 5,000,000 shares at $9.00-$11.00 per share. Prime Number Capital and Shengang Securities served as the underwriters for the IPO and Revere Securities and R.F. Lafferty & Co. were co-managers.

How do I buy shares of Meihua International Medical Technologies?

Shares of MHUA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Meihua International Medical Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Meihua International Medical Technologies investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Intel (INTC), MSP Recovery (LIFW), Palo Alto Networks (PANW), Adobe (ADBE).

Company Calendar

• Today: 9/26/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:MHUA
• CIK: 1835615
• Web: meihuamed.com
• Phone: 8605-14-8980-0199
• Fax: N/A
• Employees: 620
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 5.71
• Quick Ratio: 5.66

Sales & Book Value

• Annual Sales: $96.90 million
• Price / Sales: 0.13
• Cash Flow: $0.43 per share
• Price / Cash Flow: 0.88
• Book Value: $6.34 per share
• Price / Book: 0.06

Miscellaneous

• Outstanding Shares: 31,900,000
• Free Float: 10,669,000
• Market Cap: $12.12 million
• Optionable: Not Optionable
• Beta: 0.79